Lamivudine antiviral compound: Collaborator Glaxo began Phase III trials

BioChem Pharma Inc., Laval, Quebec Product: Lamivudine antiviral compound Indication: Hepatitis B Status: Collaborator Glaxo began Phase III trials in the Far East and Europe, with similar trials to b...